Group Futurista presents “Future of Next-Generation Sequencing for Life Sciences” Virtual Summit

Tallinn, Estonia, 2021-Oct-06 — /EPR Network/ — Group Futurista, the leading global events company, has announced its “Future of Next-Generation Sequencing for Life Sciences” Virtual Summit on 6th October 2021 at 15:00 BST/10:00 EST. It will be a unique platform with 150+ attendees, interesting knowledge sessions, and an intuitive panel discussion between all the amazing speakers discussing the massively parallel sequencing technology known as Next-generation sequencing (NGS) that has revolutionized the biological sciences.

The technologies surrounding NGS are developing and progressing every day. It replaces the Sanger Sequencing method and is more time and cost-effective, resulting in better sequencing output. While the Sanger method only sequences a single DNA fragment at a time, NGS is massively parallel, sequencing millions of fragments simultaneously per run. Due to this rapid and efficient process, DNA sequencing technology-based strategies have paved the way for the molecular prediction of human diseases with a precision medicine approach.

NGS has also been applied increasingly in cancer genomics research over the past decade. More recently, NGS has been adopted in clinical oncology to advance the personalized treatment of cancer. NGS has also been used actively during the COVID-19 pandemic in monitoring changes to the SARS-CoV-2 genome.

Access to the summit is free and we would like to mention our Media partner for the event, MDPI as well as our Platinum Sponsors 10XGenomics, Illumina, LevitasBio, Agilent Technologies, PGDx, Gold Sponsors, NEW ENGLAND Bio Labs, Mission Bio, and Purigen BioSystems and our silver sponsor PerkinElmer.

Speaker List:

Daria Salyakina: Director, Personalized Medicine & Health Outcomes Research, Nicklaus Children’s Health System

Pranil K.Chandra: Chief Medical Officer, and Vice President – Genomic and Molecular Pathology Services, Pathgroup, Personal Genome Diagnostics.

Robert Popovian: Chief Science Policy Officer, Global Healthy Living Foundation

Michael Oberholzer: Associate Director for product management, Illumina

Srinivas Sashidhar: Business Head – Clinical Research, myOnsite Healthcare LLC

Bellal Moghis: NGS Product Marketing, Director, Agilent Technologies

Fritz Sedlazeck: Associate Professor, Baylor College of Medicine

Razelle Kurzock: Co-Founder and Chief Medical Advisor for CureMatch

Koen De Gelas: Science & Technology Advisor at 10x Genomics

Martin Pieprzyk: CEO of LevitasBio

Chaithanya Ponnaluri: Development Scientist, New England BioLabs

Yue Wang: Technical Application Liaison, Mission Bio

Lewis Marshall: VP of R&D, Purigen Biosystems

Pedro Echave: Global Leader, NGS Product Experts, PerkinElmer Inc,

James Cooley: Sr. Marketing Manager, Assays, HTG Molecular

Jo Vandesompele: Biogazelle, CSO; UGent, Professor, Ghent University 

Jennifer Jackson: Director of Translational Science & Strategy, Personal Genome Diagnostics. (Panelist)

 

About Group Futurista

Group Futurista is a leading Global Events Company creating its own emerging Technology Summits, where creativity fosters and innovations flourish. They believe in the power of networking and connecting with innovative thinkers and brightest minds from Industries, Academia, and Government organizations at a global level. 

If you are interested in sponsoring or speaking at our future events, check out our website or directly contact us at jennifer@groupfuturista.com.